Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 78

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 78
---
 and operating expenses associated with supporting these activities. It is expected that negative cash flow from operations will continue until such time, if ever, that we receive regulatory approval to commercialize any of our products under development and/or we receive royalty or milestone revenue from any such products that exceeds our expenses.

<div align='center'>- 50 -</div>

Cash flows

|                                       |     |       2024 |   |     | Nine Months Ended 
        September, 
              2023 |   |     |       2023 |   |     |  Years Ended 
 December 31, 
         2022 |   |
|:--------------------------------------|:----|-----------:|:--|:----|------------------:|:--|:----|-----------:|:--|:----|-------------:|:--|
|                                       |     |          $ |   |     |                 $ |   |     |          $ |   |     |            $ |   |
| Cash used in operating activities     |     | (6,980,076 | ) |     |          (769,657 | ) |     | (4,158,264 | ) |     |   (1,057,103 | ) |
| Cash provided by financing activities |     | 10,566,897 |   |     |         5,609,950 |   |     |  5,609,950 |   |     |    1,246,241 |   |
| Net increase (decrease) in cash       |     |  3,586,821 |   |     |         4,840,293 |   |     |  1,451,686 |   |     |      189,138 |   |
| Cash, beginning of the year           |     |  1,719,338 |   |     |           267,652 |   |     |    267,652 |   |     |       78,514 |   |
| Cash, end of the year                 |     |  5,306,159 |   |     |         5,107,945 |   |     |  1,719,338 |   |     |      267,652 |   |

Cash flows used in operating activities

Cash flows used in operating activities for the nine months ended September 30, 2024 were $6,980,076 compared to cash flows used in operating activities of